- Home
- GBX vs BHVN Comparison
GBX vs BHVN Comparison
Compare GBX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBX
- BHVN
- Stock Information
- Founded
- GBX 1974
- BHVN 2013
- Country
- GBX United States
- BHVN United States
- Employees
- GBX N/A
- BHVN N/A
- Industry
- GBX Railroads
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- GBX Industrials
- BHVN Health Care
- Exchange
- GBX Nasdaq
- BHVN Nasdaq
- Market Cap
- GBX 1.4B
- BHVN 1.5B
- IPO Year
- GBX N/A
- BHVN 2017
- Fundamental
- Price
- GBX $47.15
- BHVN $15.86
- Analyst Decision
- GBX Hold
- BHVN Strong Buy
- Analyst Count
- GBX 2
- BHVN 15
- Target Price
- GBX $59.50
- BHVN $56.07
- AVG Volume (30 Days)
- GBX 268.1K
- BHVN 2.1M
- Earning Date
- GBX 10-22-2025
- BHVN 08-11-2025
- Dividend Yield
- GBX 2.74%
- BHVN N/A
- EPS Growth
- GBX 88.14
- BHVN N/A
- EPS
- GBX 7.10
- BHVN N/A
- Revenue
- GBX $3,533,700,000.00
- BHVN N/A
- Revenue This Year
- GBX N/A
- BHVN N/A
- Revenue Next Year
- GBX N/A
- BHVN $2,002.87
- P/E Ratio
- GBX $6.57
- BHVN N/A
- Revenue Growth
- GBX 0.70
- BHVN N/A
- 52 Week Low
- GBX $37.77
- BHVN $12.79
- 52 Week High
- GBX $71.06
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- GBX 52.50
- BHVN 55.58
- Support Level
- GBX $45.44
- BHVN $15.28
- Resistance Level
- GBX $47.50
- BHVN $17.25
- Average True Range (ATR)
- GBX 1.02
- BHVN 0.85
- MACD
- GBX 0.14
- BHVN 0.08
- Stochastic Oscillator
- GBX 69.23
- BHVN 53.97
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.